SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 271 filers reported holding SEATTLE GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $34,000 | +61.9% | 174 | +38.1% | 0.01% | +50.0% |
| Q2 2020 | $21,000 | +320.0% | 126 | +100.0% | 0.01% | +166.7% |
| Q3 2018 | $5,000 | -61.5% | 63 | -68.8% | 0.00% | -57.1% |
| Q2 2018 | $13,000 | +18.2% | 202 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $11,000 | 0.0% | 202 | 0.0% | 0.01% | +20.0% |
| Q4 2017 | $11,000 | +22.2% | 202 | +28.7% | 0.01% | 0.0% |
| Q3 2017 | $9,000 | – | 157 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
| Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
| Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
| Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
| DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
| Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
| EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
| Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
| CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |